目次

Table of Contents

1. Coronavirus (COVID-19) Current Therapy Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction
6.1. Segmentation By Geography
6.2. Segmentation By Drug Type
6.3. Segmentation By End Users

7. Coronavirus (COVID-19) Current Therapy Market Characteristics
7.1. Market Definition
7.2. Market Segmentation By Drug Type
7.2.1. Antiviral
7.2.2. Monoclonal Antibodies (Mabs)
7.2.3. Corticosteroid
7.2.4. Supplements
7.2.5. Antimalarial
7.2.6. Interferons And Interleukin Inhibitors
7.2.7. Other Anti-Infective Drugs
7.2.8. Others
7.3. Market Segmentation By End-Users
7.3.1. Hospitals
7.3.2. Clinics
7.3.3. Homecare
7.3.4. Others

8. Coronavirus (COVID-19) Current Therapy Market Trends And Strategies
8.1. Monoclonal Antibody Therapy
8.2. Cell-Based Therapy
8.3. Antiviral Therapy
8.4. Immunomodulators
8.5. Public Investments
8.6. Strategic Collaborations
8.7. AI and machine learning to tackle COVID-19
8.8. Convalescent Blood Plasma Therapy

9. Impact Of COVID-19 On The Coronavirus (COVID-19) Current Therapy Market
9.1. Impact Of Virus Mutations On The Market
9.2. Government Initiatives And Funding
9.3. Impact On Companies
9.4. Impact On Regulatory Framework of Pharmaceutical Products
9.5. Future Outlook

10. Global Coronavirus (COVID-19) Current Therapy Market Size And Growth
10.1. Market Size
10.2. Historic and Forecast Market Growth, 2020-2021, 2021 - 2025F, Value ($ Million)
10.2.1. Drivers Of The Market 2020 - 2025
10.2.2. Restraints On The Market 2020 - 2025

11. Global Coronavirus (COVID-19) Current Therapy Market Segmentation
11.1. Global Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)
11.2. Global Coronavirus (COVID-19) Current Therapy Market, Segmentation By End-User, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)

12. Coronavirus (COVID-19) Current Therapy Market, Regional And Country Analysis
12.1. Global Coronavirus (COVID-19) Current Therapy Market, By Region, Historic and Forecast, 2020 - 2025F, Value ($ Million)
12.2. Global Coronavirus (COVID-19) Current Therapy Market, By Country, Historic and Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)

13. Asia-Pacific Coronavirus (COVID-19) Current Therapy Market
13.1. Asia-Pacific Coronavirus (COVID-19) Current Therapy Market Overview
13.1.1. Region Information
13.1.2. Market Information
13.1.3. Background Information
13.1.4. Government Initiatives
13.1.5. Regulations
13.1.6. Regulatory Bodies
13.1.7. Major Associations
13.1.8. Taxes Levied
13.1.9. Corporate Tax Structure
13.1.10. Investments
13.1.11. Major Companies
13.2. Asia-Pacific Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 - 2025F, Value ($ Million)
13.3. Asia-Pacific Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)
13.4. Asia-Pacific Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)
13.5. Asia-Pacific Coronavirus (COVID-19) Current Therapy Market: Country Analysis
13.6. China Coronavirus (COVID-19) Current Therapy Market
13.7. China Coronavirus (COVID-19) Current Therapy Market Overview
13.7.1. Country Information
13.7.2. Market Information
13.7.3. Background Information
13.7.4. Government Initiatives
13.7.5. Regulations
13.7.6. Regulatory Bodies
13.7.7. Major Associations
13.7.8. Taxes Levied
13.7.9. Corporate Tax Structure
13.7.10. Investments
13.7.11. Major Companies
13.8. China Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 - 2025F, Value ($ Million)
13.9. China Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)
13.10. China Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)
13.11. India Coronavirus (COVID-19) Current Therapy Market
13.12. India Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 - 2025F, Value ($ Million)
13.13. India Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)
13.14. India Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)
13.15. Japan Coronavirus (COVID-19) Current Therapy Market
13.16. Japan Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 - 2025F, Value ($ Million)
13.17. Japan Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)
13.18. Japan Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)
13.19. Australia Coronavirus (COVID-19) Current Therapy Market
13.20. Australia Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 - 2025F, Value ($ Million)
13.21. Australia Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)
13.22. Australia Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)
13.23. Indonesia Coronavirus (COVID-19) Current Therapy Market
13.24. Indonesia Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 - 2025F, Value ($ Million)
13.25. Indonesia Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)
13.26. Indonesia Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)
13.27. South Korea Coronavirus (COVID-19) Current Therapy Market
13.28. South Korea Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 - 2025F, Value ($ Million)
13.29. South Korea Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)
13.30. South Korea Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)

14. Western Europe Coronavirus (COVID-19) Current Therapy Market
14.1. Western Europe Coronavirus (COVID-19) Current Therapy Market Overview
14.1.1. Region Information
14.1.2. Market Information
14.1.3. Background Information
14.1.4. Government Initiatives
14.1.5. Regulations
14.1.6. Regulatory Bodies
14.1.7. Major Associations
14.1.8. Taxes Levied
14.1.9. Corporate Tax Structure
14.1.10. Investments
14.1.11. Major Companies
14.2. Western Europe Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 - 2025F, Value ($ Million)
14.3. Western Europe Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)
14.4. Western Europe Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)
14.5. Western Europe Coronavirus (COVID-19) Current Therapy Market: Country Analysis
14.6. UK Coronavirus (COVID-19) Current Therapy Market
14.7. UK Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 - 2025F, Value ($ Million)
14.8. UK Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)
14.9. UK Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)
14.10. Germany Coronavirus (COVID-19) Current Therapy Market
14.11. Germany Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 - 2025F, Value ($ Million)
14.12. Germany Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)
14.13. Germany Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)
14.14. France Coronavirus (COVID-19) Current Therapy Market
14.15. France Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 - 2025F, Value ($ Million)
14.16. France Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)
14.17. France Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)

15. Eastern Europe Coronavirus (COVID-19) Current Therapy Market
15.1. Eastern Europe Coronavirus (COVID-19) Current Therapy Market Overview
15.1.1. Region Information
15.1.2. Market Information
15.1.3. Background Information
15.1.4. Government Initiatives
15.1.5. Regulations
15.1.6. Regulatory Bodies
15.1.7. Major Associations
15.1.8. Taxes Levied
15.1.9. Corporate Tax Structure
15.1.10. Investments
15.1.11. Major Companies
15.2. Eastern Europe Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 - 2025F, Value ($ Million)
15.3. Eastern Europe Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)
15.4. Eastern Europe Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)
15.5. Eastern Europe Coronavirus (COVID-19) Current Therapy Market: Country Analysis
15.6. Russia Coronavirus (COVID-19) Current Therapy Market
15.7. Russia Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 - 2025F, Value ($ Million)
15.8. Russia Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)
15.9. Russia Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)

16. North America Coronavirus (COVID-19) Current Therapy Market
16.1. North America Coronavirus (COVID-19) Current Therapy Market Overview
16.1.1. Region Information
16.1.2. Market Information
16.1.3. Background Information
16.1.4. Government Initiatives
16.1.5. Regulations
16.1.6. Regulatory Bodies
16.1.7. Major Associations
16.1.8. Taxes Levied
16.1.9. Corporate Tax Structure
16.1.10. Investments
16.1.11. Major Companies
16.2. North America Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 - 2025F, Value ($ Million)
16.3. North America Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)
16.4. North America Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)
16.5. North America Coronavirus (COVID-19) Current Therapy Market: Country Analysis
16.6. USA Coronavirus (COVID-19) Current Therapy Market
16.7. USA Coronavirus (COVID-19) Current Therapy Market Overview
16.7.1. Region Information
16.7.2. Market Information
16.7.3. Background Information
16.7.4. Government Initiatives
16.7.5. Regulations
16.7.6. Regulatory Bodies
16.7.7. Major Associations
16.7.8. Taxes Levied
16.7.9. Corporate Tax Structure
16.7.10. Investments
16.7.11. Major Companies
16.8. USA Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 - 2025F, Value ($ Million)
16.9. USA Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)
16.10. USA Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)

17. South America Coronavirus (COVID-19) Current Therapy Market
17.1. South America Coronavirus (COVID-19) Current Therapy Market Overview
17.1.1. Region Information
17.1.2. Market Information
17.1.3. Background Information
17.1.4. Government Initiatives
17.1.5. Regulations
17.1.6. Regulatory Bodies
17.1.7. Major Associations
17.1.8. Taxes Levied
17.1.9. Corporate Tax Structure
17.1.10. Investments
17.1.11. Major Companies
17.2. South America Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 - 2025F, Value ($ Million)
17.3. South America Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)
17.4. South America Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)
17.5. South America Coronavirus (COVID-19) Current Therapy Market: Country Analysis
17.6. Brazil Coronavirus (COVID-19) Current Therapy Market
17.7. Brazil Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 - 2025F, Value ($ Million)
17.8. Brazil Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)
17.9. Brazil Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)

18. Middle East Coronavirus (COVID-19) Current Therapy Market
18.1. Middle East Coronavirus (COVID-19) Current Therapy Market Overview
18.1.1. Region Information
18.1.2. Market Information
18.1.3. Background Information
18.1.4. Government Initiatives
18.1.5. Regulatory Bodies
18.1.6. Major Associations
18.1.7. Taxes Levied
18.1.8. Corporate Tax Structure
18.1.9. Investments
18.1.10. Major Companies
18.2. Middle East Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 - 2025F, Value ($ Million)
18.3. Middle East Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)
18.4. Middle East Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)

19. Africa Coronavirus (COVID-19) Current Therapy Market
19.1. Africa Coronavirus (COVID-19) Current Therapy Market Overview
19.1.1. Region Information
19.1.2. Market Information
19.1.3. Background Information
19.1.4. Government Initiatives
19.1.5. Regulations
19.1.6. Regulatory Bodies
19.1.7. Major Associations
19.1.8. Taxes Levied
19.1.9. Corporate Tax Structure
19.1.10. Investments
19.1.11. Major Companies
19.2. Africa Coronavirus (COVID-19) Current Therapy Market, Historic And Forecast Market Growth, 2020-2021, 2021 - 2025F, Value ($ Million)
19.3. Africa Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)
19.4. Africa Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic And Forecast, 2020-2021, 2021 - 2025F, Value ($ Million)

20. Coronavirus (COVID-19) Current Therapy Global Market Competitive Landscape
20.1. Company Profiles
20.2. Gilead Sciences, Inc.
20.2.1. Company Overview
20.2.2. Products And Services
20.2.3. Business Strategy
20.2.4. Financial Overview
20.3. F. Hoffmann-La Roche AG
20.3.1. Company Overview
20.3.2. Products And Services
20.3.3. Business Strategy
20.3.4. Financial Overview
20.4. Ipca Laboratories Limited
20.4.1. Company Overview
20.4.2. Products And Services
20.4.3. Business Strategy
20.4.4. Financial Overview
20.5. Zydus Cadila
20.5.1. Company Overview
20.5.2. Products And Services
20.5.3. Business Strategy
20.5.4. Financial Overview
20.6. Regeneron Pharmaceuticals, Inc.
20.6.1. Company Overview
20.6.2. Products And Services
20.6.3. Business Strategy
20.6.4. Financial Overview

21. Coronavirus (COVID-19) Current Therapy Market Pipeline Analysis

22. Key Mergers And Acquisitions In The Coronavirus (COVID-19) Current Therapy Global Market
22.1. Sanofi Acquired Translate Bio
22.2. Merck Acquired OncoImmune
22.3. Novartis Collaborated With Molecular Partners AG
22.4. Roche Holding AG Collaborated With Atea Pharmaceuticals
22.5. Orgenesis Inc. Acquired Koligo Therapeutics, Inc.
22.6. Sorrento Therapeutics, Inc. Acquired SmartPharm Therapeutics, Inc.
22.7. Eli Lily and Company Collaborated With Amgen
22.8. Pfizer Inc. Partnered With Gilead Sciences, Inc.
22.9. Junshi Biosciences Collaborated With Eli Lilly And Company
22.10. Neurimmune Partnered With Ethris
22.11. Abcellera Collaborated With Eli Lilly And Company

23. Coronavirus (COVID-19) Current Therapy Market Opportunities And Strategies
23.1. Global Coronavirus (COVID-19) Current Therapy Market In 2025 - Growth Strategies
23.1.1. Market Trend Based Strategies
23.1.2. Competitor Strategies

24. Coronavirus (COVID-19) Current Therapy Market, Conclusions and Recommendations
24.1. Conclusions
24.2. Recommendations
24.2.1. Product
24.2.2. Place
24.2.3. Price
24.2.4. Promotion
24.2.5. People

25. Appendix
25.1. Market Data Sources
25.2. Research Methodology
25.3. Currencies
25.4. Research Inquiries
25.5. The Business Research Company
25.6. Copyright and Disclaimer